David Abadi - Cognyte Software Chief Officer
| CGNT Stock | USD 9.10 0.05 0.55% |
Insider
David Abadi is Chief Officer of Cognyte Software
| Age | 51 |
| Address | 33 Maskit, Herzliya, Israel, 4673333 |
| Phone | 972 9 962 4004 |
| Web | https://www.cognyte.com |
Cognyte Software Management Efficiency
Return On Tangible Assets is likely to gain to -0.02 in 2025. Return On Capital Employed is likely to gain to -0.01 in 2025. At this time, Cognyte Software's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 11 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 472.9 M in 2025. Cognyte Software's management efficiency ratios could be used to measure how well Cognyte Software manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Shiri Hilton | Innoviz Technologies | N/A | |
| Joaquin CastrilloSalgado | Evertec | 41 | |
| Basie Kok | Lesaka Technologies | N/A | |
| Jonny Harvey | Taboola | N/A | |
| Lincoln Mali | Lesaka Technologies | 57 | |
| Patrick Costello | CSG Systems International | N/A | |
| BS CMAR | Champions Oncology | N/A | |
| Scott Prugh | CSG Systems International | N/A | |
| Oren Buskila | Innoviz Technologies | 39 | |
| John CFA | CSG Systems International | N/A | |
| Osnat Tirosh | Cellebrite DI | 55 | |
| Stephen Walker | Taboola | 55 | |
| Robert Scudiere | Verint Systems | N/A | |
| Dhruv Chopra | Lesaka Technologies | 50 | |
| Maria Mancini | Champions Oncology | N/A | |
| Michael MBA | Champions Oncology | N/A | |
| Lisa Cole | Cellebrite DI | 49 | |
| David MBA | Champions Oncology | 56 | |
| Steven CA | Lesaka Technologies | 59 | |
| Adam Singolda | Taboola | 42 | |
| Paul Battaglia | Cellebrite DI | N/A | |
Management Performance
| Return On Equity | -0.0163 | ||||
| Return On Asset | -9.0E-4 |
Cognyte Software Leadership Team
Elected by the shareholders, the Cognyte Software's board of directors comprises two types of representatives: Cognyte Software inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cognyte. The board's role is to monitor Cognyte Software's management team and ensure that shareholders' interests are well served. Cognyte Software's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cognyte Software's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dean Ridlon, Head Relations | ||
| Ronny Lempel, Chief Officer | ||
| Miki Migdal, Chief Officer | ||
| Ilan Rotem, Chief Officer | ||
| Elad Sharon, CEO Director | ||
| Avi Schechter, Chief Officer | ||
| Rini Karlin, Chief Officer | ||
| Efi Nuri, Chief Officer | ||
| Gil Cohen, Chief Officer | ||
| Sharon Chouli, Chief Officer | ||
| Amir Barel, Chief Officer | ||
| David Abadi, Chief Officer | ||
| Ziv Levi, Chief Officer |
Cognyte Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cognyte Software a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0163 | ||||
| Return On Asset | -9.0E-4 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 596.4 M | ||||
| Shares Outstanding | 72.97 M | ||||
| Shares Owned By Insiders | 4.72 % | ||||
| Shares Owned By Institutions | 74.77 % | ||||
| Number Of Shares Shorted | 413.15 K | ||||
| Price To Earning | 105.36 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cognyte Stock Analysis
When running Cognyte Software's price analysis, check to measure Cognyte Software's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognyte Software is operating at the current time. Most of Cognyte Software's value examination focuses on studying past and present price action to predict the probability of Cognyte Software's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognyte Software's price. Additionally, you may evaluate how the addition of Cognyte Software to your portfolios can decrease your overall portfolio volatility.